Neoadjuvant trabectedin may be an alternative to standard chemotherapy for patients with high-grade myxoid liposarcoma of the extremities or trunk, according to researchers.
News
Stereotactic ablative radiotherapy has demonstrated safety and efficacy in patients with oligometastatic soft tissue sarcoma, according to researchers.
Anti-PD-L1 agent induces sustained responses seen in about one-third of patients with advanced alveolar soft part sarcoma.
Pembrolizumab yielded responses in patients with chordoma, desmoplastic small round cell tumors, epithelioid sarcoma, and other rare sarcomas.
Researchers described possible associations between Kaposi sarcoma and Koebner phenomenon in a case series of patients with lesions appearing after a prior cutaneous injury.
Researchers explored the possibility of an intratumoral microbiome being present in soft tissue sarcoma, similar to other cancer types.
The location of KIT mutations is associated with response to ripretinib and sunitinib in patients with previously treated GIST, research suggests.
Findings with preoperative radiotherapy administered to dose of 42.75 Gy in 15 fractions for three weeks.
Adding trabectedin to doxorubicin doubled the median progression-free survival.
There was no significant difference in overall survival between patients who received actinomycin-D and those who received carboplatin.